Here are three things to know.
1. The population-based study included women in British Columbia, Canada, with one or more autoimmune diseases who had pregnancies between Jan. 1, 2002, and Dec. 31, 2012.
2. The study authors defined exposure to biologics as having at least one biologic prescription three months before or during pregnancy.
3. There was no statistically significant difference in preterm delivery or small-for-gestational-age births between babies exposed to biologics and non-exposed babies.
More articles on biologics:
MedImmune to create standalone biologics company Viela Bio: 5 things to know
Biologics, opioids will be magic words at AAOS 2018 meeting: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
